Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
851
-
Total 13F shares, excl. options
-
131M
-
Shares change
-
+4.64M
-
Total reported value, excl. options
-
$20.1B
-
Value change
-
+$613M
-
Put/Call ratio
-
1.37
-
Number of buys
-
359
-
Number of sells
-
-470
-
Price
-
$152.92
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q4 2024
1,071 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q4 2024.
BIOGEN INC. - Common Stock (BIIB) has 851 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 131M shares
of 147M outstanding shares and own 89.26% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (16.7M shares), PRIMECAP MANAGEMENT CO/CA/ (16M shares), BlackRock, Inc. (15.5M shares), STATE STREET CORP (7.4M shares), WELLINGTON MANAGEMENT GROUP LLP (4.93M shares), GEODE CAPITAL MANAGEMENT, LLC (3.7M shares), T. Rowe Price Investment Management, Inc. (3.1M shares), Pacer Advisors, Inc. (2.67M shares), NORGES BANK (2.33M shares), and Invesco Ltd. (2.13M shares).
This table shows the top 851 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.